In line with our results, previous research has demonstrated significant overexpression (> 10-fold) of S100A8 in pancreatic adenocarcinoma, whereas S100A8 and S100A9 were rarely expressed in normal pancreatic tissue and tissue of chronic pancreatitis [28–30]. This evidence concerns the gene S100A9 and pancreatic adenocarcinoma.